Replies to post #240272 on Innovation Pharmaceuticals Inc (IPIX)

[djs7]

Agree, previously it was B-OM in a Business Development agreement. Now B-IBD has been included.

[Amatuer17]

That is Leo for you - hiding bad news with some bread crumbs.

He literally misled everyone on P-2B results for so long - he did not pay the CRO and that’s why there are no results- what a shame.
Exactly shows how he runs the show as grocery store owner.

[Amatuer17]

So what is your defense of Leo’s screw up and misleading information on P 2B results?

B-ABSSI derisked the-investment as per your off-repeated statement. They shelved B- ABSSI. Any defense?

[loanranger]

"The company will be staying in the current office. Scroll down to Lease Commitments"

You might want to read that again. How about I post it (pardon the layout...no time to fix it):

Lease Commitments



Operating Leases – Rental Property



The Company signed a lease extension agreement with Cummings Properties which began on October 1, 2013. The lease is for a term of five years ending on September 30, 2018, and requires monthly payments of $18,000. Innovative Medical Research Inc., a company owned by Leo Ehrlich and Dr. Krishna Menon, officers of the Company, has co-signed the lease.



As of June 30, 2018, future minimum lease payments to Cummings Properties required under the non-cancelable operating lease are as follows (rounded to nearest thousand):



Year ending June 30,







2019



$ 54,000


Total minimum payments



$ 54,000